Log in to save to my catalogue

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2123849115

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

About this item

Full title

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2016-12, Vol.375 (26), p.2519-2529

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

This randomized trial involving patients with osteoarthritis or rheumatoid arthritis who were at increased cardiovascular risk showed the noninferiority of celecoxib to naproxen or ibuprofen with respect to cardiovascular safety.
Nonsteroidal antiinflammatory drugs (NSAIDs) were introduced in the 1960s and became the most widely prescribed class...

Alternative Titles

Full title

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2123849115

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2123849115

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1611593

How to access this item